Vanguard Group Inc
- SEC CIK
- 0000102909
- Latest filing
- Jan 29, 2026
ACXP holding history
Acurx Pharmaceuticals, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ACXP overviewAll 13F holders of ACXPFull Q4 2025 holdings
- Shares (Q4 2025)
- 23,280
- Value
- $58.0K
- % of portfolio
- <0.1%
- Quarters held
- 11
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 23,280 | $58.0K | <0.1% | +23,280 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −7,277−100.0% | Sold outConverted for a 1-for-20 split | Holders |
| Q2 2025 | 145,537 | $74.4K | <0.1% | −383,812−72.5% | Reduced | Holders |
| Q1 2025 | 529,349 | $206.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 529,349 | $430.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 529,349 | $1.01M | <0.1% | +37,662+7.7% | Added | Holders |
| Q2 2024 | 491,687 | $1.11M | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 491,687 | $1.20M | <0.1% | +85,300+21.0% | Added | Holders |
| Q4 2023 | 406,387 | $1.56M | <0.1% | +285,143+235.2% | Added | Holders |
| Q3 2023 | 121,244 | $181.9K | <0.1% | +200+0.2% | Added | Holders |
| Q2 2023 | 121,044 | $320.8K | <0.1% | +31,559+35.3% | Added | Holders |
| Q1 2023 | 89,485 | $309.6K | <0.1% | +89,485 | New | Holders |